Arash Bahremand

839 total citations
27 papers, 700 citations indexed

About

Arash Bahremand is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Arash Bahremand has authored 27 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Arash Bahremand's work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Arash Bahremand is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Arash Bahremand collaborates with scholars based in Iran, Canada and Australia. Arash Bahremand's co-authors include Ahmad Reza Dehpour, Mehdi Ghasemi, Reza Rahimian, Borna Payandemehr, Pouya Ziai, Hamed Shafaroodi, Sara Ebrahimi Nasrabady, Abbas Ghasemi, Mohammad Sharifzadeh and Gohar Fakhfouri and has published in prestigious journals such as European Journal of Pharmacology, Addiction and Neuropharmacology.

In The Last Decade

Arash Bahremand

27 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arash Bahremand Iran 18 342 203 189 137 105 27 700
Jennifer N. Pearson-Smith United States 14 248 0.7× 216 1.1× 139 0.7× 85 0.6× 98 0.9× 18 794
S.K. Kulkarni India 20 357 1.0× 237 1.2× 69 0.4× 103 0.8× 124 1.2× 46 1.1k
Francielle Mina Brazil 22 215 0.6× 291 1.4× 103 0.5× 108 0.8× 220 2.1× 36 1.1k
Mehrak Javadi‐Paydar Iran 19 362 1.1× 259 1.3× 71 0.4× 174 1.3× 210 2.0× 43 924
Sattar Ostadhadi Iran 20 365 1.1× 247 1.2× 113 0.6× 222 1.6× 158 1.5× 56 982
Jo Sourbron Belgium 17 283 0.8× 180 0.9× 379 2.0× 102 0.7× 106 1.0× 26 744
Arvin Haj‐Mirzaian Iran 18 228 0.7× 276 1.4× 69 0.4× 129 0.9× 125 1.2× 34 1.1k
Ze‐Hui Gong China 18 451 1.3× 459 2.3× 111 0.6× 124 0.9× 234 2.2× 62 957
Nastaran Kordjazy Iran 16 265 0.8× 185 0.9× 65 0.3× 148 1.1× 93 0.9× 20 798
Matilde Otero‐Losada Argentina 17 212 0.6× 226 1.1× 59 0.3× 61 0.4× 148 1.4× 65 942

Countries citing papers authored by Arash Bahremand

Since Specialization
Citations

This map shows the geographic impact of Arash Bahremand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Bahremand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Bahremand more than expected).

Fields of papers citing papers by Arash Bahremand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Bahremand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Bahremand. The network helps show where Arash Bahremand may publish in the future.

Co-authorship network of co-authors of Arash Bahremand

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Bahremand. A scholar is included among the top collaborators of Arash Bahremand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Bahremand. Arash Bahremand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharafi, Heidar, Sarah Drouin, Stephanie Coronado‐Montoya, et al.. (2023). Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials. Addiction. 119(2). 211–224. 9 indexed citations
2.
Sharafi, Heidar, Arash Bahremand, Sarah Drouin, et al.. (2023). Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Drug and Alcohol Dependence. 253. 111018–111018. 3 indexed citations
3.
Tatar, Ovidiu, Amal Abdel‐Baki, Alina Dyachenko, et al.. (2023). Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study. Psychiatry Research. 326. 115276–115276. 2 indexed citations
4.
Bahremand, Arash, et al.. (2020). Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. Journal of Dual Diagnosis. 16(2). 191–207. 28 indexed citations
5.
Payandemehr, Borna, Arash Bahremand, Ali Ebrahimi, et al.. (2015). Protective effects of lithium chloride on seizure susceptibility: Involvement of α2-adrenoceptor. Pharmacology Biochemistry and Behavior. 133. 37–42. 15 indexed citations
6.
Ghasemi, Mehdi, et al.. (2014). Effect of Biliary Cirrhosis on Neurogenic Relaxation of Rat Gastric Fundus and Anococcygeus Muscle: Role of Nitric Oxide Pathway. Digestive Diseases and Sciences. 59(11). 2675–2681. 2 indexed citations
7.
Payandemehr, Borna, Reza Rahimian, Maziar Gooshe, et al.. (2014). Nitric oxide mediates the anticonvulsant effects of thalidomide on pentylenetetrazole-induced clonic seizures in mice. Epilepsy & Behavior. 34. 99–104. 28 indexed citations
8.
Derakhshanian, Hoda, et al.. (2012). Quercetin improves bone strength in experimental biliary cirrhosis. Hepatology Research. 43(4). 394–400. 14 indexed citations
9.
Payandemehr, Borna, Arash Bahremand, Reza Rahimian, et al.. (2012). 5-HT3 receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: Involvement of nitric oxide. Epilepsy Research. 101(3). 217–227. 42 indexed citations
10.
Montaser‐Kouhsari, Laleh, Borna Payandemehr, Pouya Ziai, et al.. (2011). A role for opioid system in the proconvulsant effects of sildenafil on the pentylenetetrazole-induced clonic seizure in mice. Seizure. 20(5). 409–413. 21 indexed citations
11.
Fakhfouri, Gohar, Reza Rahimian, Mohammad R. Rasouli, et al.. (2011). Sildenafil attenuates TNBS‐induced colitis in rats: possible involvement of cGMP and KATP channels. Fundamental and Clinical Pharmacology. 26(2). 190–193. 9 indexed citations
12.
Bahremand, Arash, Pouya Ziai, Borna Payandemehr, et al.. (2011). Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: Involvement of α2-adrenoceptor. European Journal of Pharmacology. 666(1-3). 93–99. 16 indexed citations
13.
Bahremand, Arash, Sara Ebrahimi Nasrabady, Pouya Ziai, et al.. (2010). Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice. Epilepsy Research. 89(2-3). 295–302. 48 indexed citations
14.
Rahimian, Reza, Gohar Fakhfouri, Ali Daneshmand, et al.. (2010). Adenosine A2A receptors and uric acid mediate protective effects of inosine against TNBS-induced colitis in rats. European Journal of Pharmacology. 649(1-3). 376–381. 32 indexed citations
15.
Ghasemi, Mehdi, Hamed Shafaroodi, Pouria Heydarpour, et al.. (2010). Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice. Epilepsy & Behavior. 18(3). 171–178. 34 indexed citations
16.
Ghasemi, Abbas, Mohammad Reza Saberi, Mehdi Ghasemi, et al.. (2010). Administration of lithium and magnesium chloride inhibited tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice. Epilepsy & Behavior. 19(4). 568–574. 13 indexed citations
17.
Ghasemi, Mehdi, Hamed Shafaroodi, Abbas Ghasemi, et al.. (2010). Inhibition of NMDA receptor/NO signaling blocked tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice. Epilepsy Research. 91(1). 39–48. 34 indexed citations
18.
Bahremand, Arash, Sara Ebrahimi Nasrabady, Hamed Shafaroodi, Mehdi Ghasemi, & Ahmad Reza Dehpour. (2009). Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice. Epilepsy Research. 84(2-3). 110–119. 41 indexed citations
19.
Bahremand, Arash, Hamed Shafaroodi, Mehdi Ghasemi, et al.. (2008). The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice. Epilepsy Research. 81(1). 44–51. 33 indexed citations
20.
Gholizadeh, Shervin, Hamed Shafaroodi, Mehdi Ghasemi, et al.. (2007). Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Neuropharmacology. 53(6). 763–770. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026